Answers are grounded in this paper and cite their sources.
A hybrid metallic prodrug for targeting PR-positive breast cancer therapy was prepared, which revealed significantly in vivo antitumor effect.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: